Explainer · Real-world evidence
Reading between the codes: clinical NLP in two minutes
Most of what we know about a patient is buried in free text. How natural language processing gets it out, and why health economists should care.
Read · 4 min readInsights
Health economics is only useful if the people deciding can follow it. Here are our explainers, peer-reviewed work, evaluation reports and briefings.
Publications & reports
- In preparationWhite paperEconomic evaluation of the Jefferson County Public Schools stock albuterol programKanotra A.Revised to CHEERS 2022 reporting standards
- 2023Peer-reviewed articleUse of conditionally essential amino acids and the economic burden of postoperative complications after fracture fixation: results from a cost-utility analysisShafrin J, Than K-S, Kanotra A, Kerr KW, Robinson KN, Willey MC.ClinicoEconomics and Outcomes Research 2023;15:753–764
- 2023Evaluation planRetrospective Economic Evaluation: Kentucky Asthma Management Program — Individual Evaluation PlanKanotra A.Kentucky Department for Public Health. Approved by CDC (NUE1EH001372)
- 2020Journal articleHeterogeneous effects of unemployment on mental health, depending on gender and refugee status: evidence from Germany and the United StatesKanotra A, Neitzel K, Modi M, Yang X, Thomas A.Rationale 2020;1:1–28
- 2019MSc dissertationEconomics of pricing a novel antibiotic for Clostridium difficile infection in the United KingdomKanotra A.London School of Economics and Political Science
- 2016Honors thesisThe effect of Medicaid expansion on emergency department utilizationKanotra A.University of Louisville, College of Arts & Sciences Senior Honors Theses, Paper 104
Briefings & teaching
July 2025
Preliminary results: economic evaluation of the JCPS stock albuterol program
Briefing to the Kentucky Asthma Management Program, CDC and school health coordinators
Workshop series
Economic evaluation methods, in three parts
For state agencies and chronic-disease coalitions, Kentucky Asthma Management Program
Work with us
Tell us about the launch, the coverage question or the program that needs to show its value. We will tell you what evidence it needs, and what it can do without.